Molecular biomarkers in colorectal carcinoma

Pharmacogenomics. 2015;16(10):1189-222. doi: 10.2217/PGS.15.63. Epub 2015 Aug 3.

Abstract

Colorectal cancer is a tumor with increasing incidence which represents one of the first leading causes of death worldwide. Gene alterations described for colorectal cancer include genome instability (microsatellite and chromosomal instability), CpG islands methylator phenotype, microRNA, histone modification, protein biomarkers, gene mutations (RAS, BRAF, PI3K, TP53, PTEN) and polymorphisms (APC, CTNNB1, DCC). In this article, biomarkers with prognostic value commonly found in colorectal cancer will be reviewed.

Keywords: BRAF; KRAS; colorectal carcinoma.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Colorectal Neoplasms / genetics*
  • CpG Islands / genetics
  • DNA Methylation / genetics
  • Genomic Instability / genetics
  • Humans
  • MicroRNAs / genetics
  • Prognosis

Substances

  • Biomarkers, Tumor
  • MicroRNAs